Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from ...

First Alleged U.S. Death from Defective Glucose Monitors Prompts Legal Action—7 Deaths Reported Globally, 3 Million Devices Recalled ONTARIO, Calif., Feb.

LINK_UP_REGION Your region. Used to determine the correct LibreLinkUp service (Possible values: AE, AP, AU, CA, DE, EU, EU2, FR, JP, US, LA, RU, CN) EU LINK_UP ...

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...

Health care technology company Abbott has recalled certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems because the sensors are displaying incorrect glucose ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...

In 2024, J. Cole shocked hip-hop fans when he broke what felt like a cardinal rule in hip-hop by apologizing to Kendrick Lamar at the peak of the Lamar vs. Drake beef. Now, two years later, the rapper ...